Anemia in elderly market seen reaching $4.59 billion by 2030

The Business Research Company says the global anemia in elderly market is growing as aging populations expand and diagnosis improves. The market is projected to rise from $3.26 billion in 2026 to $4.59 billion by 2030, with Asia-Pacific expected to be the fastest-growing region.

Why it matters: - The anemia in elderly market is tied to the health needs of a rapidly aging population. - Growth in diagnosis, treatment options and outpatient care could expand access for older adults with anemia. - The forecast points to rising demand for geriatric healthcare services through 2030.

What happened: - The Business Research Company released an anemia in elderly market report dated October 30, 2026. - The report projects the market will grow from $2.99 billion in 2025 to $3.26 billion in 2026. - The report expects the market to reach $4.59 billion by 2030. - The forecast implies a 9.0% CAGR from 2025 to 2026 and an 8.9% CAGR through 2030. - The report says North America held the largest market share in 2025. - The report says Asia-Pacific will be the fastest-growing region during the forecast period.

The details: - The report links near-term growth to an expanding aging population, higher rates of chronic disease, wider availability of oral iron supplements, hospital-based anemia care and greater awareness of nutritional deficiencies. - The forecast period is supported by demand for personalized anemia treatments, long-acting injectable therapies, outpatient management services and better diagnostic screening for elderly patients. - The report identifies broader adoption of combination therapy, increased use of injectable iron formulations, earlier diagnosis in seniors, home-based treatment options and improved management of chronic-condition-related anemia as emerging trends. - The report defines anemia in the elderly as reduced red blood cells or hemoglobin levels below normal in adults typically 65 and older. - The condition can stem from nutritional deficiencies, chronic illness or physiological changes associated with aging. - The market analysis covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report also says its 2026 edition includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspot infographics, key technology analysis and future trend analysis. - The report offers a free sample and a full report.

Between the lines: - The market thesis rests on demographics more than a single treatment breakthrough. - The strongest demand appears to come from older adults with chronic disease, where anemia management becomes part of broader long-term care. - The Asia-Pacific growth call suggests unmet need and improving healthcare capacity are converging in that region. - The report's emphasis on home-based treatment and outpatient services points to care moving beyond hospitals.

What's next: - Market growth will likely track aging trends, screening adoption and the rollout of more convenient anemia therapies. - Companies serving geriatric care and diagnostic markets may see more demand in Asia-Pacific and outpatient settings. - The Business Research Company says it is offering expanded strategic intelligence tools in its 2026 market reports. - Contact details provided in the release include Saumya Sahay at marketing@tbrc.info and The Business Research Company’s social media channels.